It would be a great opportunity for general public to hear from the leading diabetes expert Dr. C. Ronald Kahn, on Tuesday, Dec. 2, at the 7th Annual Presidential Distinguished Lecture series at the University of Texas Health Science Center at San Antonio.
Virginia researchers claimed to have created artificial pancreas clinical trials to test an individually-”prescribed” control algorithm, which regulates blood glucose levels in Type 1 diabetics. The computerized, subcutaneous system could one day transform the way Type 1 diabetics manage their disease.
Type 1 diabetics can now enjoy their life without worrying about the blood sugar level, as the New England Journal of Medicine has revealed about a new testing device which will automatically detect the sugar level of our body and will let us know when its low or high.
Now there is a new hope for type 1 diabetics as the researchers of Tel Aviv University has developed a new cure which is based on beta cell therapy. This beta cell therapy involves the formation of insulin producing beta cells from human tissue outside the human body and then injecting the same cells in the pancreas to make insulin. This new cure if successful will open a new way for the diabetic patient who have left no other option than organ transplant.